ON
← Back to feed
Nobel Prize in Medicine 2026: optogenetics, the technique that started with a microalgae and eventually revolutionized the study of the brain
AR🏛️ PoliticsCenter

Nobel Prize in Medicine 2026: optogenetics, the technique that started with a microalgae and eventually revolutionized the study of the brain

The 2026 Nobel Prize in Medicine was awarded to three researchers who pioneered optogenetics, a groundbreaking technique that uses light to control neurons. The winners were German scientists Peter Hegemann and Georg Nagel, along with American scientist Karl Deisseroth. Their work began with studying how algae respond to light and led to the development of tools that allow scientists to activate or inhibit specific brain cells. This has revolutionized neuroscience research, particularly in understanding neurological and psychiatric disorders. The announcement was made by Thomas Perlmann, head of the Nobel Committee, during a press conference accessible online. The prize includes $1.2 million to be shared among the three laureates.

The 2026 Nobel Prize in Physiology or Medicine has been awarded to American scientist Karl Deisseroth and German researchers Peter Hegemann and Georg Nagel for their pioneering work in optogenetics, a revolutionary technique that allows scientists to control individual neurons using light. The three scientists were recognized for their groundbreaking discoveries regarding light-gated ion channels and their application in optogenetics, which has transformed the field of neuroscience. The announcement came during a press conference held in Stockholm, where Thomas Perlmann, secretary-general of the Nobel Committee for Physiology or Medicine, revealed the names of the recipients. The award includes a total of $1.2 million, which will be shared among the three scientists. The decision was reached after extensive deliberation by the Nobel Assembly at the Karolinska Institute, based on their contributions to understanding how light can be used to manipulate neuronal activity. The origins of optogenetics trace back to a simple question posed by Hegemann: how could a single-celled green alga, Chlamydomonas, respond so quickly, within milliseconds, to changes in light? His curiosity led him to investigate the mechanisms behind this rapid response, ultimately leading to the identification of a key protein known as channelrhodopsin. This protein, found in the algal cell membrane, converts light into electrical signals by opening a channel that allows charged ions to flow into the cell, generating an electrical impulse. Hegemann collaborated with Georg Nagel at the Max Planck Institutes for Biochemistry and Biophysics, where they conducted detailed studies on the structure and function of channelrhodopsin. Their research demonstrated that this protein could be used to activate or deactivate neurons when exposed to light. By introducing the protein into other types of cells, they showed that these cells too could become photosensitive, marking a crucial step toward the development of optogenetic tools. Building upon this foundational work, Karl Deisseroth, a professor at Stanford University specializing in biomedical engineering, psychiatry, and behavioral sciences, took the concept further. He utilized a modified virus to deliver the gene encoding channelrhodopsin directly into the brains of laboratory animals. By shining blue light onto the targeted neurons, Deisseroth successfully activated specific neural circuits, enabling researchers to observe how different brain regions contribute to complex behaviors and functions. Two years later, Deisseroth developed tiny, light-sensitive fibers that could be implanted into the brains of live mice. These implants allowed for real-time manipulation of neural activity, providing unprecedented insights into the workings of the brain. This innovation has since enabled scientists to explore the neural basis of memory, emotion, and behavior, while also offering potential therapeutic applications for neurological and psychiatric conditions. The significance of their work extends beyond basic science. Optogenetics has already begun influencing clinical research, offering new avenues for treating diseases such as Parkinson’s, epilepsy, and depression. Researchers around the world are now using the technique to map the brain with greater precision than ever before, uncovering previously unknown connections between neurons and their roles in health and disease. The recognition of Deisseroth, Hegemann, and Nagel underscores the growing importance of interdisciplinary approaches in modern scientific research. Their discoveries exemplify how seemingly simple biological questions can lead to profound technological advancements with wide-ranging implications for human health and well-being.

How this report was made. Objective News wrote this report from 3 source articles, using AI-assisted synthesis under our methodology. It is our own text, not a copy of any single outlet. Read our methodology.

Responsible editor: Matej BašaSpotted an error? Report it

3 reports

Clarín logoClarínIndependentCenterFactual 95Objective 98
2026 Nobel Prize winner hopes to shed light on the brain

The article discusses the 2026 Nobel Prize winner in Medicine, an American scientist who, along with German colleagues, revolutionized neuroscience through optogenetics. This technique uses light to study the brain and has potential applications in psychiatry, particularly in improving treatments for disorders such as autism and Parkinson’s by identifying and modulating specific cells.

Bias read (Center): The article presents factual information about scientific advancements without overt ideological framing. It focuses on the technical achievements and medical implications of optogenetics, which is a scientific breakthrough rather than a politically charged issue. The tone remains neutral, avoiding褒

Why factuality (95): The article accurately reports Karl Deisseroth as the 2026 Nobel Prize winner in Medicine, his affiliation with Stanford University, and his work in optogenetics alongside Peter Hegemann and Georg Nagel. It correctly quotes him explaining the significance of using light to control specific neurons,

Why objectivity (98): The article presents information in a neutral and informative manner, quoting Deisseroth directly and providing context about the scientific impact of optogenetics. There is no evident bias, emotional language, or editorializing. The tone remains objective throughout.

La Nación logoLa NaciónIndependent🔒CenterFactual 85Objective 78
Nobel Prize in Medicine 2026: optogenetics, the technique that started with a microalgae and eventually revolutionized the study of the brain

The 2026 Nobel Prize in Medicine was awarded to three researchers who pioneered optogenetics, a groundbreaking technique that uses light to control neurons. The winners were German scientists Peter Hegemann and Georg Nagel, along with American scientist Karl Deisseroth. Their work began with studying how algae respond to light and led to the development of tools that allow scientists to activate or inhibit specific brain cells. This has revolutionized neuroscience research, particularly in understanding neurological and psychiatric disorders. The announcement was made by Thomas Perlmann, head of the Nobel Committee, during a press conference accessible online. The prize includes $1.2 million to be shared among the three laureates.

Bias read (Center): The article presents a factual account of the Nobel Prize awarding process and the scientific contributions of the recipients. It does not take a clear ideological stance, nor does it emphasize any particular political agenda. The focus remains on the scientific achievement and its implications for脑

Why factuality (85): The article accurately describes the 2026 Nobel Prize in Medicine awarded to researchers who developed optogenetics. It mentions the correct names of the winners (Peter Hegemann, Georg Nagel, Karl Deisseroth) and their contributions. The information aligns with the cross-source consensus that these

Why objectivity (78): The article presents the event in a neutral tone, focusing on the significance of the discovery and the reactions of the committee members. However, there is some promotional language when describing the impact of optogenetics, such as 'revolucionó la investigación' which implies a strong positive o

Página/12 logoPágina/12Party-alignedCenterFactual: no official source document/info detectedObjective 65
Argentine scientists explain what changed with the discoveries awarded the Nobel Prize in Medicine

The article discusses the scientific discoveries related to the Nobel Prize in Medicine, focusing on how nerve signals can be controlled through a unique protein acting as a switch. It highlights the work of Argentine researchers who contributed to the development of optogenetics, a technique that uses light to control neurons. The piece emphasizes the significance of these findings in neuroscience and their potential applications in medical treatments.

Bias read (Center): The article presents the scientific discovery in a neutral tone, focusing on the technical aspects of the research without overtly favoring any political ideology. While the topic relates to scientific advancement, which can have broader societal implications, the framing remains balanced and does

Why factuality: no official source document/info detected

Why objectivity (65): The tone is more promotional and less objective, emphasizing the change brought by the discovery without providing balanced perspectives or additional context. The focus on the implementation in Argentina suggests a potential regional bias, affecting objectivity.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.

Become a Supporter

Related stories